Charlotte Jones-Burton
Directeur/Membre du Conseil chez BLUEBIRD BIO, INC.
Fortune : 16 947 $ au 30/04/2024
Postes actifs de Charlotte Jones-Burton
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Directeur/Membre du Conseil | 07/03/2022 | - |
| Independent Dir/Board Member | 07/03/2022 | - | |
| Women of Color in Pharma | Fondateur | - | - |
| President | - | - |
Historique de carrière de Charlotte Jones-Burton
Anciens postes connus de Charlotte Jones-Burton
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 24/01/2022 | 02/10/2023 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Corporate Officer/Principal | - | - |
Otsuka Pharmaceuticals (U.K.) Ltd.
 Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Corporate Officer/Principal | - | - |
Formation de Charlotte Jones-Burton
| University of Maryland School of Medicine | Doctorate Degree |
| Washington University in St. Louis | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
Otsuka Pharmaceuticals (U.K.) Ltd.
Otsuka Pharmaceuticals (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceuticals (U.K.) Ltd. operates as an investment holding British company with interests in pharmaceutical preparations. The company is based in Slough, UK. The CEO of the company is Stewart Pearce. | Health Technology |
| Women of Color in Pharma | |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
- Bourse
- Insiders
- Charlotte Jones-Burton
- Expérience
